Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zoetis history
Zoetis company history timeline
In 1952, the Pfizer Agriculture Division opened a 732-acre research and development facility in Terre Haute, Indiana, called Vigo.
By 1988 the division was renamed Pfizer Animal Health.
The 1995 acquisition of Norden Laboratories from GlaxoSmithKline expanded Pfizer's animal health division into small animal care, including domestic pets.
Actelion profile and corporate video Actelion is a pharmaceuticals and biotechnology company established in December 1997, headquartered in Allschwil near Basel, Switzerland.
Secondary research and development centres were opened in Kalamazoo, Michigan, in 2003.
At the time, it was the largest IPO from a United States company since Facebook's $16 billion IPO on May 18, 2012.
Zoetis was founded in July 2012 and is headquartered in New York, NY.“
Records show that Pfizer officially filed for registration of a Class A stock with the United States Securities and Exchange Commission on August 10, 2012.
Zoetis' IPO on February 1, 2013 sold 86.1 million shares for US$ 2.2 billion.
On May 22, 2013, The Wall Street Journal reported that Pfizer planned to sell its majority stake in the company.
In November 2015, the company announced it would acquire a developer of aquaculture treatments and diseases, Pharmaq, for $765 million.
In 2017, Zoetis acquired Ireland-based Nexvet, a company with a biologics focused technology and product candidate pipeline.
In May 2018, the company announced its intention to acquire Abaxis for $1.9 billion in cash.
1 Excludes revenue associated with Client Supply Services, which represented 1% of total 2019 revenue.
In August 2021, Zoetis announced it would buy Jurox, increasing the business' presence in New Zealand, the US, Canada and the UK.
Rate how well Zoetis lives up to its initial vision.
Zoetis jobs
Do you work at Zoetis?
Does Zoetis communicate its history to new hires?
Zoetis competitors
| Company name | Founded date | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Merck | 1891 | $64.2B | 74,000 | 1,306 |
| Hospira | 2004 | $4.5B | 19,000 | - |
| Johnson & Johnson | 1886 | $88.8B | 134,500 | 1,782 |
| Amgen | 1980 | $33.4B | 22,000 | 625 |
| Gilead Sciences | 1987 | $28.8B | 11,800 | 734 |
| Regeneron | 1988 | $14.2B | 9,123 | 362 |
| Seagen | 1997 | $2.0B | 900 | - |
| Alpharma | 1975 | $350.0M | 2,000 | - |
| Novartis | 1996 | $51.7B | 110,000 | 409 |
| Elanco | 1954 | $4.4B | 10,200 | 123 |
Zoetis history FAQs
Zippia gives an in-depth look into the details of Zoetis, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Zoetis. The employee data is based on information from people who have self-reported their past or current employments at Zoetis. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Zoetis. The data presented on this page does not represent the view of Zoetis and its employees or that of Zippia.
Zoetis may also be known as or be related to Whitehall Laboratories Inc, Zoetis, Zoetis Inc and Zoetis Inc.